TEQCool Expands Business Target Beyond Therapeutic Hypothermia into Multi-Billion-Dollar Brain Metabolism Reduction Markets
TEQCool AB today announced a strategic repositioning of its patented non-invasive, intranasal brain cooling system technology to address the vast global market for brain metabolism reduction, expanding beyond the therapeutic hypothermia market. Addressing a Critical, Under-Served Need While dedicated standalone markets for targeted brain temperature reduction do not yet exist, the underlying demand spans multiple […]
Innovating the Future of Neurocritical Care
TEQCool AB (“TEQcool” or the “Company”) reports on progress in its product development as well as in positioning the Company and its technology on the market. Driving Progress and Innovation at TEQCoolTEQCool continues to make significant strides in the development of the world’s most targeted Brain Cooling system. With focused efforts on key milestones and […]
TEQCool strengthens the core team and builds value
We are excited to share that Vivien Ibironke Ibiyemi joined the TEQCool team as Chief Operating Officer a few weeks ago. This is significant for TEQCool as Vivien comes with a lot of experience from within Medtech and product development in different companies within both R & D and Operations. In this newsletter, we are […]